Introduction
Peptidomimetics are modied peptides which might have optimal bioavailability and biological activity.
1,2 The modica-tions usually involve N-alkylation, Ca-substitution, Ca and Nreplacement, heterocyclic generation, and backbone or sidechain transformations.
3 Among peptidomimetics, DOPA derivatives are of interest in the therapy of the Parkinson disease (PD). 4 PD is one of the most important neurodegenerative disorders, characterized by dopamine (DA) neuron loss in the substantia nigra pars compacta (SNpc) and depletion of DA content in the dorsal striatum, which causes tremors at rest, muscle rigidity, akinesia (or bradykinesia) and postural instability.
5
DOPA-containing peptides penetrate the blood brain barrier (BBB) by the aid of specic peptide-mediated carrier transport systems (PMCTS), 6 restoring adequate DA concentration in the surviving dopaminergic (DAergic) neurons. 7 They also preserve DOPA from the occurrence of fast metabolic decarboxylation, avoiding the peripheral DA-related side effects (cardiac arrhythmias, vomiting and hypotension). 8 DOPA peptides showed bioavailability and anti-PD activity higher than DOPA. The main synthetic pathway for the preparation of DOPA peptides is the solid state procedure. 10 This synthesis oen requires tedious and long-time protecting/de-protecting steps, with intrinsic low selectivity. 11 As an alternative, procedures based on the oxidative side chain modication of amino acids have been applied. 12 The synthesis of DOPA-containing peptides by selective oxidation of tyrosine residues with tyrosinase from Agaricus bisporus was reported. 13, 14 Tyrosinase (monophenol, odiphenol: oxidoreductase, E.C. 1.14.18.1) is a metalloprotein able to activate di-oxygen for the conversion of tyrosine to DOPA (creolase or monophenolase activity) and to DOPA quinone (catecholase or diphenolase activity, respectively).
15-18
The replacement of the natural amide bond in peptides with unusual covalent linkages is a general strategy to improve the stability and activity of the molecule. 19 We recently reported the synthesis of DOPA-derived peptidomimetics with stable O-C and N-C covalent bonds by oxidative functionalization of tyrosine with 2-iodoxybenzoic acid (IBX), 20 that is a biomimetic system of tyrosinase. The reaction proceeded through a Michael-like 1,4-addition of oxygen and nitrogen centred aamino acids to reactive DOPA ortho-quinone intermediate.
21
DOPA-derived peptidomimetics containing glycine residues showed the highest antioxidant effect in the 2,2-diphenyl picrylhydrazyl (DPPH) test, while valine derivatives were the most active compounds in the comet assay in L5178Y (TKAE) mouse lymphoma cells.
The role of the oxidative stress in PD has been debated and reviewed. 22 Data suggested that the oxidative damage by active radical species might contribute to the cascade of events leading to degeneration of DAergic neurons. 23 We report here that tyrosinase can be directly applied for the nucleophilic oxidative functionalization of tyrosine residues to yield DOPA-derived peptidomimetics bearing stable O-C and N-C bonds and characterized by antioxidant and antiParkinson activities. The reaction was effective under heterogeneous conditions aer immobilization of tyrosinase on multi walled carbon nanotubes (MWCNTs). The main advantages of heterogeneous catalysis derive from the easy product isolation, high enzyme loading and recyclability, thus minimizing the cost of the processes. 24 The anti-Parkinson activity of novel DOPAderived peptidomimetics was evaluated by electrophysiological recordings on individual dopaminergic neurons in rat ex vivo midbrain slices, based on the ability of novel DOPA-derived peptidomimetics to reproduce the effects of DA and DOPA observed on the DAergic neurons in physiological conditions. Indeed, the low content of DA in the basal ganglia nuclei occurring in PD is currently mainly treated with DOPA which is converted to DA by the aromatic amino acid decarboxylase enzyme. Therefore, the efficacy of potential anti-PD drugs should be expressed through their ability to mimic DA/DOPA effects.
Results and discussion

Synthesis of DOPA-derived peptidomimetics under homogeneous conditions
The tyrosine derivative Boc-Tyr-OMe (BTO) 1 protected at both the amino moiety (as tert-butoxycarbonyl; Boc, green) and carboxylic group (as methyl ester; cyano) was used as starting material. Reactions were designed according to the general procedure previously applied with IBX and are generalized in Scheme 1.
Briey, the oxidation of BTO 1 (20 mg, 0.068 mmol) with tyrosinase from Agaricus bisporus (600 UA) was performed in the presence of the appropriate a-amino acid derivative (0.68 mmol) in phosphate buffer solution (PBS; pH 7) and EtOH (from 9 : 1 v/v to 1 : 9 v/v PBS/EtOH ratio, respectively) at 25 C, followed by the reduction step with Na 2 S 2 O 4 . EtOH showed a complete miscibility and high compatibility with PBS in various enzymatic reactions. 25 Initially, glycine methyl ester (NH 2 -Gly-OMe) was used as nitrogen centred nucleophile for the addition on the reactive DOPA ortho-quinone intermediate. DOPA-derived peptidomimetic OMe-Gly-N-Boc-DOPA-OMe 2 was obtained in the highest yield (87%) in the presence of PBS/ EtOH 3 : 7 v/v aer 24 h, besides to unreacted BTO ( Fig. 1 ; Scheme 2, pathway A; Table 1 ).
The oxidative functionalization of BTO 1 was then repeated using N-Boc-glycine (Boc-Gly-COOH) as oxygen centred nucleophile under optimal conditions, to yield N-Boc-Gly-N-Boc-DOPAOMe 3 in 80% yield (Table 1, As a general trend, N-centred nucleophiles were slightly more efficient than the O-centred counterpart. Moreover, glycine nucleophiles were more reactive than valine nucleophiles, probably due to side-chain steric hindrance effects.
Synthesis of DOPA-derived peptidomimetics in heterogeneous conditions
The oxidative functionalization of BTO 1 was then performed using tyrosinase supported on multi-walled carbon nanotubes (MWCNTs) applying the Layer by Layer (LbL) procedure previously developed. 26 Briey, oxidized MWCNTs 27 were treated with a positively charged poly(diallyldimethylammonium) chloride (PDDA) to facilitate the loading of tyrosinase, that is negatively charged at the operative pH 7. Bovine Serum Albumin (BSA) was used to reduce undesired conformational changes. 28 Glutaraldehyde (GA) increased the reticulation grade and the stability of the system (Fig. 2) . 29 The structural characterization and the activity parameters of catalyst MWCNT/tyrosinase/BSA (Tyr/ MWCNTs), as well as its application in the synthesis of bioactive catechol derivatives are in ref. 26 Recycling experiments proceeded with success in the oxidation of compound BTO 1 with NH 2 -Gly-OMe as selected nucleophile. As shown in Table 1 (entries 9-13), MWCNT/Tyr was used for at least ve catalytic cycles with only a slight decrease of efficiency to give 2.
Finally, DOPA-derived peptidomimetics 2-5 were deprotected under standard conditions 30 using 6 M hydrochloric acid heating at reux for 2 h. Gly-N-C-DOPA 6 and Val-N-C-DOPA 7 were obtained in quantitative yield, while Gly-O-C-DOPA 8 and Val-O-C-DOPA 9 were isolated in 73% and 68% yield respectively, probably due to the competitive hydrolysis of the novel C-O bond (Scheme 3).
Evaluation of anti-Parkinson activity
Preliminary studies showed that DOPA-derived peptidomimetics 2-5 were characterized by an antioxidant activity higher than that of the corresponding DOPA-containing peptides. 20 On a BTO 1 (20 mg, 0.068 mmol) was treated with tyrosinase from Agaricus bisporus (600 UA) and different a-amino acid residues (0.68 mmol) in PBS/ EtOH (3 : 7 v/v; mL) at 25 C for 24 h, followed by the reduction step with Na 2 S 2 O 4 . b BTO 1 (20 mg, 0.068 mmol) was treated with Tyro/MWCNT (600 UA) and different a-amino acid residues in PBS/EtOH (3 : 7 v/v; 12 mL) at 25 C for 24 h, followed by the reduction step with Na 2 S 2 O 4 . c Reusability is expressed as the yield in % of DOPA-derived peptidomimetic 2 obtained by oxidation of BTO 1 with MWCTN/Tyr under optimal conditions. the basis of these data, we decided to evaluate the anti-PD effect of peptidomimetics 2-9 (protected and deprotected forms) on DAergic neurons. Since PD is characterized by low content of DA in the basal ganglia nuclei, potential anti-PD drugs should mimic the effects of DA and/or DOPA. Thus, the activity of DOPA-derived peptidomimetics 2-9 was evaluated by measuring the effects on single neuron ring/membrane currents in comparison to those evoked by exogenous DA/ DOPA applied to DAergic neurons of the rat substantia nigra pars compacta (SNpc). 31 Simultaneous neuronal ring of a large population of neurons located in the SNpc was recorded by multi electrode array (MEA). Spontaneously active neurons were rstly challenged with DA (30 mM, 2 min, Fig. 3A ) and only neurons that were inhibited by DA (>15% spontaneous ring inhibition); 32 were considered in the present study. Similarly, the effect of the DOPA-derived peptidomimetics 2-9 was evaluated in those DA sensitive neurons, which responded to drug perfusion with at least a 15% change in ring rate.
We recorded 39 neurons inhibited by DA, and in 33 of them the application of Gly-N-C-DOPA 6, (300 mM) caused a slow onset ring inhibition that was completely reversed by the D2 receptor antagonist sulpiride (10 mM; Fig. 3 , panels A and B). The extent of ring inhibition by Gly-N-C-DOPA 6 paralleled that of DA. Indeed, the effect of Gly-N-C-DOPA 6 was more pronounced (P ¼ 0.00014; Fig. 3 , panel B) in those DA-sensitive neurons that were strongly inhibited by DA (74.66 AE 7.07%, N ¼ 17), compared to those (P ¼ 0.041; Fig. 3 , panel C) inhibited by DA by a lesser extent (35.96 AE 9.03%, N ¼ 16). In 6 out of the 39 SNpc DA neurons, Gly-N-C-DOPA 6 (300 mM) did not cause ring inhibition (<15%), although they responded to DA with 26.73 AE 10.88% ring inhibition (data not shown). To further investigate the neuronal response to Gly-N-C-DOPA 6 we performed voltage clamp experiments from single DA neurons. We found that application of Gly-N-C-DOPA 6 activated a slowly developing outward current of about 60 pA in 1 out of 3 DAergic neurons tested (Fig. 3, panel F) . This current was completely blocked by the D2 receptor antagonist sulpiride. In the remaining 2 neurons Gly-N-C-DOPA 6 was ineffective. By contrast, the protected form OMe-Gly-N-Boc-DOPA-OMe 2 (300 mM) did not cause signicant modications of ring activity of DAergic neurons (N ¼ 40, P ¼ 0.36744; Fig. 3D and E) . These data suggested that the deprotection of 2 was a key step for the appearance of DA-like effects in the subpopulation of DAergic neurons. Since Gly-N-C-DOPA 6 cannot release DA due to the stable N-C linkage between the amino acid residues, the observed activity could be explained by the direct interaction with D2 receptors in the extracellular environment.
We then tested the DA/DOPA-like effects of OMe-Val-NBoc-DOPA-OMe 4 and Val-N-C-DOPA 7, respectively. We recorded 15 SNpc neurons inhibited by DA, and in 12 of these neurons the application of Val-N-C-DOPA 7 (300 mM) caused a pronounced (P ¼ 0.000001) ring inhibition. This inhibition was completely reversed by the D2 receptor antagonist sulpiride (10 mM; Fig. 4, panels A and B) . In these experiments, 3 out of 15 DAergic neurons were insensitive to Val-N-C-DOPA 7, (300 mM; <15%) despite they displayed an inhibition by DA of 84.34 AE 0.79% (data not shown). In a large set of population (53 out of 62) of SNpc neurons inhibited by DA OMe-Val-N-Boc-DOPAOMe 4 (300 mM) caused marked ring inhibition (Fig. 4 , panels C and D), however, differently from Val-N-C-DOPA 7, the cellular inhibition seemed to be unspecic, as it was not reversed by sulpiride.
These results were further conrmed by patch-clamp recordings. In the example trace of Fig. 4 (panel E), OMe-Val-N-Boc-DOPA-OMe 4 caused an outward current that was insensitive to sulpiride. By contrast, the outward current was completely blocked by the K ATP channel blocker tolbutamide (100 mM). These data suggested that OMe-Val-N-Boc-DOPA-OMe 4 caused ring inhibition through a mechanism other than D2 receptor stimulation, possibly involving a drop in intracellular ATP content, which causes K ATP channel opening. In alternative, the direct action on K ATP channels in SNpc DAergic neurons cannot be completely ruled out.
33
In 9 out of the 62 SNpc DAergic neurons OMe-Val-N-Boc-DOPA-OMe 4 (300 mM) did not cause ring inhibition (<15%), although they responded to DA with 85.78 AE 6.49% ring inhibition (data not shown). Note that O-C DOPA-derived peptidomimetics 3, 5, 8 and 9, were not active under the same experimental conditions, suggesting a structure activity relationships between the inhibition of neuronal ring and evoked outward currents of DAergic neurons and the type of covalent bond. Future experiments will address the possible mechanisms underlying Gly-N-C-DOPA 6 and Val-N-C-DOPA 7 mediated activation of D2 receptors, and their ability to enter DAergic neurons.
Experimental
Materials
Mushroom tyrosinase from Agaricus bisporus (Tyr), multi-walled carbon nanotubes (MWCNTs), L-tyrosine, bovine serum albumin (BSA), glutaraldehyde (GA), polydiallyldimethylammonium chloride (PDDA), sodium sulfate anhydrous (Na 2 SO 4 ), Boc-tyrosine-OMe, amino acids differently protected and organic solvents were purchased from SigmaAldrich. All spectrophotometric measurements were made with a Varian Cary50 UV-Vis spectrophotometer equipped with a Peltier thermostatted single cell holder. 1 
Preparation of catalyst MWCNT/Tyr
MWCNT/Tyr was prepared as previously reported. 26 Briey, PDDA coated MWCNTs in PBS were treated with a mixture of Tyr (0.2 mg) and BSA (0.6 mg) for 30 minutes. Glutaraldehyde (GA, 2.5%) was added to reach a nal volume of 800 mL and the mixture was shaken at 25 C for 30 min and at 4 C overnight.
The excess enzyme and GA were removed by centrifugation (4000g Â 20 min) and the surnatant was used for the calculation of activity parameters. The catalyst was nally treated with 1.5 mL TRIS-HCl 0.1 M pH 7.2 by shaking for 1 h at 4 C and centrifuged. MWCNT/Tyr was washed several times with PBS in order to ensure the complete removal of unbounded Tyr (as evaluated by the Bradford method).
Activity data
The activity of native and immobilized Tyr was determined by measuring the oxidation of L-tyrosine. The reaction was started by adding L-tyrosine to the solution of Tyr or MWCNT/Tyr in PBS under magnetic stirring. The initial rates were measured as linear increase in optical density at 475 nm, due to dopachrome formation. One unit of enzyme activity was dened as the increase in absorbance of 0.001 per minute at pH 7, 25 C in a 3.0 mL reaction cuvette containing 0.83 mM of L-tyrosine and 67 mM of PBS pH 7.0. The activity was expressed as activity unit per milligram of support:
where U x is the activity of the immobilized enzyme assayed by dopachrome method. The activity yield represents the % of the ratio of activity of the immobilized enzyme to the total units of native enzyme used:
where U a is the total activity of enzyme (unit) added in the solution and U r is the activity of the residual Tyr (unit) evaluated by dopachrome method in the washing solutions. The immobilization yield is dened as:
General procedure for preparation of DOPA-derived peptidomimetics BTO 1 (0.068 mmol) was dissolved in 12 mL of EtOH/PBS v/v, then amino acid (0.68 mmol) and tyrosinase from Agaricus bisporus or Tyr/MWCNT (600 UA) were added. The reaction mixture was stirred at 25 C for 24 h. The reaction was monitored by thin layer chromatography (TLC, n-hexane/EtOAc ¼ 2.0 : 1.0). Aer the disappearance of substrate, the reaction mixture was treated with 2 mL of H 2 O and 2.0 eq. of Na 2 S 2 O 4 stirring for 15 min. Then was added 2 mL of saturated solution of NaHCO 3 and stirring for 30 min. The mixture was extracted several time with AcOEt and separated from H 2 O. The organic layer were collected dried with Na 2 SO 4 and concentrated under reduced pressure. The crude product was puried by ash-chromatography.
Compounds Gly-N-C-DOPA 6, Val-N-C-DOPA 7, Gly-O-C-DOPA 8, and Val-O-C-DOPA 9 were obtained from compounds 2, 3, 4 and 5 respectively using an aqueous solution of HCL 6 M for 2 h at reux. The crude was then concentrated under reduced pressure and washed with hexane to yield the desired products.
Spectroscopic data
OMe-Gly-N-Boc-DOPA-OMe (2 Multi-electrode assay recordings. Extracellular signals were acquired on a planar multi-electrode array (MEA) device using the MED64 System (Alpha MED Sciences, Osaka, Japan). Horizontal midbrain slices (300 mm) were placed over an 8 Â 8 array of planar microelectrodes, each 20 Â 20 mm in size, with an interpolar distance of 100 mm (MED-P2105, Alpha MED Sciences, Osaka, Japan) as previously described. 32 Signals were low-cut ltered at 100 Hz and digitized at 100 kHz using Mobius soware (Alpha MED Sciences, Osaka, Japan). The fast transients corresponding to spontaneous action potentials were captured off-line and sorted using Spike2 6.0 soware (Cambridge Electronic Design Ltd, Cambridge, UK). The basal ring frequency was measured over a period of 3 min, before challenging the slices with a 30 s perfusion of DA 30 mM. The relative change in ring frequency was calculated by the mean frequency during the last few seconds of DA perfusion with respect to the control period. Only cells that were inhibited by DA, with inhibition exceeding 15% of control ring, were considered in the present study.
Whole cell patch clamp recordings in SNpc DAergic neurons. Recordings were performed accordingly to Mercuri et al. 34 SNpc DAergic neurons, localized in a region of tightly packed neurons adjacent to the medial terminal nucleus of the accessory optic tract, were identied based on a slow and regular spontaneous ring (1-5 Hz), hyperpolarizing/outward response to dopamine (DA, 30 mM), prominent I h in response to hyperpolarizing voltage steps (À60 to À120 mV, 20 mV increment, holding potential, V h , À60 mV) 35 and, in current-clamp mode, a depolarizing sag upon application of negative currents.
36 Patch pipettes (2-5 MU) were lled with a solution containing (in mM): K-gluconate (135), CaCl 2 (0.1), MgCl 2 (2), KCl (10), EGTA (0.75), HEPES (10), Mg 2 -ATP (4), and Na 3 -GTP (0.3), phosphocreatine-Na 2 (10), pH 7.3, osmolarity 280 mOs L À1 .
Conclusions
DOPA-derived peptidomimetics bearing unusual O-C and N-C bonds have been efficiently prepared by a novel tyrosinase mediated oxidative functionalization process, based on the nucleophilic addition of appropriate amino acids on the reactive ortho-quinone intermediate of tyrosine residues. The reaction was effective also under heterogeneous conditions using tyrosinase immobilized on multi walled carbon nanotubes. We have found that peptidomimetics Gly-N-C-DOPA 6 and Val-N-C-DOPA 7, bearing a stable N-C covalent bond between the amino acid residues displayed DA/DOPA-like effects in the majority of SNpc DAergic neurons. Gly-N-C-DOPA 6 and Val-N-C-DOPA 7 caused a strong inhibition of ring activity via D2 receptor activation, and similarly to DA/DOPA, activated the D2 receptormediated outward current that was blocked by the selective D2 receptor antagonist sulpiride. However, in a subpopulation of SNpc DAergic neurons poorly sensitive to DA, Gly-N-C-DOPA 6 and Val-N-C-DOPA 7 exerted only a mild effects. The reason of this discrepancy among different types of SNpc DAergic neurons remains unknown, even if a different membrane expression of functional aromatic aminoacid transporters can be reasonably involved.
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